Summary
- Current Price
- As of today, URGN price is $45.60, down -1.79% on
- Current Price All-Time High
- URGN price is currently -34.45% below its historical high of $69.57 set on
- Market Cap
- URGN current market cap is $2B, up +140.33% over the past 365 days
- Revenue
- URGN current annual revenue is $109.79M, up +21.45% year-over-year
- Next Earnings
- The next earnings release for URGN is on
Profile
| Metric | Value |
|---|---|
| Full Name | UroGen Pharma Ltd. |
| Ticker | NASDAQ: URGN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | urogen.com |
| Employees | 234 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $45.60 | |
| Price, 1D Change | -1.79% | |
| $2B | ||
| - | ||
| - | ||
| 1.11 | ||
| $109.79M | ||
| Revenue, 1Y Change | +21.45% | |
| -$3.19 | ||
| EPS, 1Y Change | -7.81% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$3.19 | ||
| EPS Estimate | -$0.71 | N/A |
| EPS Est. Change | +77.90% | N/A |
| $109.79M | ||
| Revenue Estimate | $276.49M | N/A |
| Revenue Est. Change | +151.84% | N/A |
| Current Price | $45.60 | |
| Price Target | $44.00 | - |
| Price Tgt. Change | -3.51% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.13 | -$2.96 | +5.38% | |
| -$3.15 | -$3.19 | -1.32% | |
| -$0.71 | N/A | +77.90% | |
| $1.49 | N/A | +146.83% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $91.00M | $90.40M | -0.66% | |
| $111.87M | $109.79M | -1.86% | |
| $276.49M | N/A | +151.84% | |
| $435.30M | N/A | +296.49% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $45.60 | |
| $25.60 | ||
| $35.79 | ||
| $27.02 | ||
| $36.65 | ||
| $1.88 | ||
| 1.11 | ||
| $2.45 | ||
| 67.07 | ||
| 97.94% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $109.79M | ||
| -$3.19 | ||
| $97.34M | ||
| 88.66% | ||
| -$124.86M | ||
| -113.73% | ||
| -$153.49M | ||
| -139.81% | ||
| -$122.45M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| -1.23 | ||
| 4.01 | ||
| 3.65 | ||
| - | ||
| 2 | ||
| -3.02 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 15.81 | ||
| -17.88 | ||
| -21.56 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$105.47M | ||
| $121.81M | ||
| $200.46M | ||
| $186.02M | ||
| $305.93M | ||
| $46.42M | ||
| $130.09M | ||
| $1.76M | ||
| $12.14M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $263.28M | ||
| $222.20M | ||
| $12.45M | ||
| $0.00 | ||
| $2.41M | ||
| $0.00 | ||
| $78.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$162.44M | ||
| $61.56M | ||
| $39.92M | ||
| $289.00K | ||
| -$162.73M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Guggenheim | → | |
| Oppenheimer | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Oppenheimer | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → |
Analyst sentiment
Institutional ownership
No data
Screeners with URGN
FAQ
- What is the ticker symbol for UroGen Pharma Ltd.?
- The ticker symbol for UroGen Pharma Ltd. is NASDAQ:URGN
- Does UroGen Pharma Ltd. pay dividends?
- No, UroGen Pharma Ltd. does not pay dividends
- What sector is UroGen Pharma Ltd. in?
- UroGen Pharma Ltd. is in the Healthcare sector
- What industry is UroGen Pharma Ltd. in?
- UroGen Pharma Ltd. is in the Biotechnology industry
- What country is UroGen Pharma Ltd. based in?
- UroGen Pharma Ltd. is headquartered in United States
- When did UroGen Pharma Ltd. go public?
- UroGen Pharma Ltd. initial public offering (IPO) was on May 4, 2017
- Is UroGen Pharma Ltd. in the S&P 500?
- No, UroGen Pharma Ltd. is not included in the S&P 500 index
- Is UroGen Pharma Ltd. in the NASDAQ 100?
- No, UroGen Pharma Ltd. is not included in the NASDAQ 100 index
- Is UroGen Pharma Ltd. in the Dow Jones?
- No, UroGen Pharma Ltd. is not included in the Dow Jones index
- When was UroGen Pharma Ltd. last earnings report?
- UroGen Pharma Ltd.'s most recent earnings report was on August 5, 2026
- When does UroGen Pharma Ltd. report earnings?
- The next expected earnings date for UroGen Pharma Ltd. is November 5, 2026
Data Sources & References
- URGN Official Website www.urogen.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1668243/000143774926006234/0001437749-26-006234-index.htm
- URGN Profile on Yahoo Finance finance.yahoo.com/quote/URGN
- URGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/urgn